Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
IV |
ATC code | |
Pharmacokinetic data | |
Protein binding | ~30% |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ECHA InfoCard | 100.035.149 |
Chemical and physical data | |
Formula | C52H74N16O15S2 |
Molar mass | 1227.37 g/mol |
3D model (Jmol) | |
|
|
|
|
Terlipressin (trade names Teripress by New Medicon Pharma and Glypressin by Ferring Pharmaceuticals) is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used to treat bleeding esophageal varices.
Terlipressin is currently not available in the United States, or Canada, but it is available in New Zealand, Australia, much of Europe, India & UAE.
Terlipressin must not be used during pregnancy.